Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Bioassay-directed fractionation of organic contaminants in an estuarine sediment using the new mutagenic bioassay, mutatox (trade name)

Technical Report ·
OSTI ID:6334442

Bioassay-directed fractionation of organic compounds was performed on an organic solvent extract of a contaminated estuarine sediment from Black Rock Harbor, Connecticut, using the new mutagenic bioassay, Mutatox. Chemical fractionation methods of the sediment extract included silica-gel-column chromatography (SGCC), followed by C-18 reverse phase HPLC. Compound identification was performed using GC-MS. Mutatox analyses indicated that four of the eight HPLC fractions contained mutagenic or epigenetic compounds. GC-MS analyses detected known mutagenic polycyclic aromatic hydrocarbons (PAHs) in two of the four mutagenic fractions. GC-MS analyses of the other two mutagenic fractions (one operational blank and one sediment fraction) showed no known mutagenic compounds. SGCC and HPLC, combined with the Mutatox bioassay, were useful in reducing both the number and the complexity of fractions analyzed by GC-MS.

Research Organization:
Environmental Protection Agency, Narragansett, RI (United States). Environmental Research Lab.
OSTI ID:
6334442
Report Number(s):
PB-93-194504/XAB; EPA--600/J-93/183
Country of Publication:
United States
Language:
English